Logo
G

GeneDx

825 employees

We see a world where every genetic condition is understood, and every patient receives the care their need to live their fullest life. Our approach to genetic testing, along with having one of the world's most diverse rare disease data sets, makes us a catalyst for clear, connected and actionable care. Named one of Fast Company's Most Innovative Companies of 2025, we're leading the way to a future where we end the diagnostic odyssey. It all begins with a single test.

Investor insights

Funding rounds participated in

$150M sweet spot round size

Investor type

Public Company

Basic info

Industry

Biotechnology Research

Sectors

Biotechnology Research

Funding rounds raised

Total raised

$150M

from investors over 1 rounds

G

GeneDx raised $150M on February 27, 2023

FAQ